We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS SEEKS INPUT ON STREAMLINING PRODUCT DEVELOPMENT PROCESS
HHS SEEKS INPUT ON STREAMLINING PRODUCT DEVELOPMENT PROCESS
May 24, 2004
HHS has established a public docket for input on how the department and its operating agencies -- including the FDA, the National Institutes of Health and the Centers for Medicare & Medicaid Services (CMS) -- can expedite the development and approval of new drugs and biologicals.